Sample size, n |
33 |
33 |
|
Age (years), mean ± SD |
40.37 ± 7.58 |
38.25 ± 7.62 |
|
Days since symptoms to enrollment, mean ± SD |
95 ± 5.68 |
98 ± 6.27 |
|
Gender (male/female), n |
13/20 |
15/18 |
|
Smokers (current/never), n |
5/28 |
4/29 |
1.00 |
Comorbidities, n |
|
|
|
Asthma
|
2
|
3
|
1.00
|
Diabetes
|
7
|
8
|
1.00
|
Hypertension |
7 |
8 |
1.00 |
Migraine |
2 |
4 |
0.67 |
Sinusitis |
3 |
2 |
1.00 |
Current medication
|
Anti-histamine
Metformin
B- blocker
ACE inhibitor
Sumatriptan
Paracetamol
|
Anti- histamine
Glipizide
Amlodipine
ACE inhibitor
Paracetamol
|
|
Previous anosmia
treatment
|
None (n=12)
Topical steroids (n=10)
Systemic + topical steroids (n=11)
|
None (n=14)
Topical steroids (n=9)
Systemic + topical steroids (n=7)
Vitamin A (n=3)
|
|